SMHI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient buyer. While the chart is technically bullish, SMHI is pushing into near-term resistance (R1 ~6.87) with weak/declining fundamentals, no fresh catalysts or news tailwinds, and no proprietary buy signals today. I’d wait rather than chase here; if already owned, it’s a hold into the next setup rather than adding now.
Trend/structure: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) indicates an uptrend. Momentum: MACD histogram is positive (0.0915) and expanding, supporting continued upside momentum; RSI(6) ~63 is neutral-to-slightly bullish (not overbought). Levels: Pivot 6.44. Price 6.85 is trading just below R1 6.872 (immediate overhead resistance). Next resistance R2 7.138. Supports: S1 6.008 then S2 5.742. Tactical read: Technically constructive, but the risk/reward for an impatient entry is less attractive when buying directly into resistance. A cleaner entry would be either (a) a pullback toward ~6.44–6.50 that holds, or (b) a convincing breakout and hold above ~6.87 with follow-through toward ~7.14.
Intellectia Proprietary Trading Signals
Technical uptrend remains intact (bullish MA alignment + positive, expanding MACD).
Options market positioning is strongly call-tilted (bullish sentiment).
Potential technical catalyst if SMHI breaks and holds above ~6.87 (R1), opening a path toward ~7.14 (R2).
Fundamental trend is deteriorating (latest quarter shows YoY declines in revenue and profitability).
No news/catalyst in the past week to justify chasing price into resistance.
Pattern-based projection provided indicates downside bias over the next week (-3.61%).
Upcoming earnings: QDEC 2025 on 2026-02-25 after hours with an EPS estimate of -0.65 (event risk and potentially negative narrative if weakness persists).
Market backdrop slightly risk-off (S&P 500 -0.5% on the session).
Latest reported quarter: 2025/Q3. Revenue: 59.19M, down -14.11% YoY (contraction). Net income: 8.99M, down -155.02% YoY (sharp deterioration vs prior-year baseline). EPS: 0.35, down -159.32% YoY. Overall: The top-line and earnings trend is negative, which conflicts with the bullish technical setup and makes buying aggressively at resistance unattractive right now.
No analyst rating or price target change data was provided, so there’s no clear Wall Street consensus signal to lean on. Pros from the data: bullish technicals and call-heavy options positioning. Cons from the data: weakening YoY financial performance and an earnings event ahead with a negative EPS estimate.
Influential/political flows: Hedge funds and insiders are neutral (no significant recent trends). No recent Congress trading data available, and no politician/influential figure transactions were provided.
